Glenmark Pharmaceuticals begins clinical trial of anti-myeloma drug
GBR 1342 simultaneously targets CD38, as well as the CD3 T cell co-receptor
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin, Cadila Healthcare recall drugs in US
The drugs were recalled on account of failed dissolution specification and presence of foreign tablets/capsules
Mylan launches chronic hepatitis B treatment tabs
The tablet has been launched in the strength of 25 mg
SCHOTT Glass receives accolades
Wins top awards at vendor meet organised by Borosil Klasspack
ICT-BIRAC Biosimilar Workshop 2017 to be held in Mumbai
The five-day workshop will focus on practical hands-on training on characterisation of biosimilars
Anand Nambiar, MD, Merck, gets new assignment in Germany
Nambiar will become the Head of the Integrated Circuit Materials' business unit within Merck's Performance Materials Business at…
Indiabulls Pharmaceuticals receives Rs 155-crore capital from Clermont Group
The company will provide next generation therapies to patients at affordable prices
Shilpa Med gets 10 observations from US FDA
The facility is located at Jadcherla in Telangana
Suven Life Sciences secures product patents in Eurasia and Norway
The patents are valid through 2034 and 2026 respectively
Datwyler Pune plant to be ready by year end
First samples to be supplied in July 2018, facility expected to create about 500 jobs by the end of 2018
AHWP’s 22nd conference kickstarts
The conference is being conducted by CDSCO and NDRA of India in collaboration with Ministry of Health & Family Welfare
D2L lays foundation for major global expansion
Appoints Marcus Bergler as its Vice President Global Sales
Govt to set up expert panel for drug pricing, new launches
According to an order, the recommendations of this committee shall be considered by the NPPA which shall pass a reasoned order…
ARDSI, Mumbai Chapter and ALKEM organise ‘Awarathon Mumbai 2017’
Spread awareness on dementia
EMA accepts USV’s marketing authorisation application of proposed biosimilar Pegfilgrastim
Pegfilgrastim reduces the duration of Neutropenia and decreases the chances of infection
Five ways to address talent challenges
The pharma industry is finding it difficult to source and retain its existing talent pool. Thammaiah BN, MD, Kelly Services India,…
AYUSH industry may create 25 mn jobs by 2020
According to Suresh Prabhu, Union minister of Commerce and Industry, the government is eyeing a three-fold increase in the AYUSH…
Cadila Pharmaceuticals organises Walk-a-thon
Creates awareness on AIDS on World Aids Day
US FDA approves Mylan and Biocon’s Ogivri
It is the first biosimilar for Trastuzumab, for the treatment of HER2-Positive breast and gastric cancers